Does the hypoxic cytotoxin SR 4233 increase the effectiveness of radioimmunotherapy in mice with human non-Hodgkin 's lymphoma xenografts?
A first generation hypoxic cytotoxin, SR 4233, was able to enhance the tumor growth delay produced by radioimmunotherapy in severe combined immunodeficient phenotype mice with human cutaneous T cell lymphoma xenografts.
Inexpensive, noncommercial bibs are effective and improve tracheal climate and benefit patients with laryngectomies. © 2015 Wiley Periodicals, Inc. Head Neck 38: E480-E487, 2016.